Attached files
| file | filename |
|---|---|
| 8-K - Xtant Medical Holdings, Inc. | v207041_8k.htm |
Bacterin
International Holdings to Present
at
the OneMedForum San Francisco 2011
BELGRADE, MT, – January 3, 2011 – Bacterin International
Holdings, Inc. (“Bacterin”) (OTCBB: BIHI), today announced that it
is scheduled to present at the upcoming OneMedForumSF 2011, Emerging Company
Finance Conference, on Tuesday, January 11, 2011, at 8:30 a.m. (PT) at the Sir
Francis Drake Hotel in San Francisco, CA. Guy Cook, founder, chairman
and CEO of Bacterin will present the Company’s operations and its strategic
positioning.
Bacterin,
founded in 1998 and based near the nation’s leading research center
for biofilm engineering, is a creator and developer of revolutionary bone graft
material and anti-infective coatings for medical applications.
The
Bacterin presentation will be broadcast live over the Internet and can be
accessed at http://www.ustream.tv/channel/onemedforum
or through the Company’s website at www.bacterin.com.
OneMedForum
takes place January 11-13, 2011 in San Francisco, CA during the world’s largest
gathering of healthcare financiers and executives. The Forum will feature
presentations by over 100 of the world’s most promising emerging life science
public and private companies. In 2010, over 1,000 investors participated in the
conference, to learn more about the forum, visit www.onemedplace.com.
Guy Cook
commented, “The OneMedForumSF is a great venue for Bacterin to meet with
prospective investors and showcase the achievements we’ve accomplished to date,
as well elaborate on the Company’s potential. As indicated on our
third quarter earnings release, we have grown revenue to $10.1 million during
the first nine months of 2010, as compared to $5.2 million for the comparable
period in 2009, and expect to deliver total revenue for 2010 of $15-$17 million,
as we indicated in our third quarter earnings conference call. These
are exciting times for Bacterin. We look forward to introduce our business to
new investors and update current shareholders at OneMedForumSF this
month.”
About Bacterin International
Holdings, Inc.
Bacterin
International Holdings, Inc. (“Bacterin”) develops, manufactures and
markets biologics products to domestic and international
markets. Bacterin’s proprietary methods optimize the growth factors
in human allografts to create the ideal stem cell scaffold and promote bone and
other tissue growth. These products are used in a variety of
applications including enhancing fusion in spine surgery, relief of back pain by
facet joint stabilization, promotion of bone fusion in foot and ankle surgery,
promotion of cranial healing following neurosurgery and subchondral bone defect
repair in articulating joint surgeries.
Bacterin’s
Medical Device division develops anti-microbial coatings based upon proprietary
coating technologies. Bacterin develops, employs, and licenses bioactive
coatings for various medical device applications. Bacterin’s
strategic coating initiatives include antimicrobial coatings designed to inhibit
biofilm formation and microbial contamination on medical devices drug delivery,
local (as opposed to systemic) pain management, and anti-thrombotic factors for
medical device applications.
Headquartered
in Belgrade, Montana, Bacterin operates a 32,000 square foot, state-of-the-art,
fully compliant and FDA registered facility, equipped with four "Class 100"
clean rooms. For further information please visit www.bacterin.com.
About
OneMedForum
Founded
in 2008, OneMedForum events are held biannually in San Francisco in January and
in New York in June. They are designed to create a communications platform for
emerging companies to connect with strategic partners and
investors. The New
York Forum was designated OneMedForum Days in New York in recognition of the
important work..
About OneMedPlace
OneMedPlace
is a virtual community of healthcare and life science companies. It has, for the
first time, put in place the innovations that will shape the future of health
and medicine—emerging companies and technologies seeking capital, distribution,
visibility, and investors and strategic partners looking for health and medical
innovations to invest in, acquire, license, distribute, purchase or
utilize.
Contact:
Yvonne L.
Zappulla
Managing
Director
Grannus
Financial Advisors, Inc.
212-681-4108
or
Guy
Cook
President
& CEO
Bacterin
International Holdings, Inc.
406-388-0480
gcook@bacterin.com
Certain statements in this news
release may constitute “forward-looking” statements within the meaning of
section 21E of the Securities and Exchange Act of 1934. Our
forward-looking statements include earnings guidance and other statements
regarding our expectations and beliefs. The Company believes that its
expectations, as expressed in these statements are based on reasonable
assumptions regarding the risks and uncertainties inherent in achieving those
expectations. These statements are not, however, guarantees of future
performance and actual results may differ materially. Risks and uncertainties
which may cause actual results to be different than expressed or implied in our
forward-looking statements include, but are not limited to, the risk factors
described under the heading “Risk Factors” in Amendment No. 1 to our Form S-1
filed December 7, 2010. The Company expressly disclaims any current
intention to update any forward-looking statements as a result of new
information or future events or developments.